Search results

Thanks Surf, but it seems like all of that stuff was a lifetime ago... All the Best! :cool:

Riiiiight. In 1998, Niederhoffer got clobbered and "carried" out of the S&P Futures Options pit on the CME because of his absurd naked put selling. A buddy of mine (Mike Goodwin, the #2 trader at Deutsche Bank Equity Derivatives next to Ralph Reynolds) got a call from his floor clerk on the...

http://en.wikipedia.org/wiki/Stanley_Druckenmiller He left Soros in late 2000 after the Quantum Fund sustained large losses on high tech stocks (like BVSN, JNPR, SUNW, etc. ) during the Dot-Com bubble busting... It was then, that Soros decided to change his Fund back to a Family Endowment...

I was a COMEX floor trader back in 1986 for Paul Tudor Jones and met Monroe through a friend of mine that was in the Silver pit. My buddy lived in New Canaan, CT along with Monroe. Monroe would occasionally come over to my buddies estate (7 acres) and we'd play everything from "3 on 3"...

That's BS. Guess you've never heard of George's right hand man of many years, Stanley Druckenmiller.

The same thing happened with Raj Rajaratnam and Galleon Group. A totally legit fund, and then Raj got into this competitive "game" with others about who could obtain the BEST information. Ego, Ego, and more Ego. Sinks ships.

The pre-market tape got "painted" by the shorts and idiots were tripping all over themselves to sell shares out down to $6.61 because they felt that the pre-cancer sensitivity number at 42% was significant. If you had command of the fundamental FACTS of what this test has just achieved in the...

They traded up to a close of $1.20 Old fashioned Bear Raid today after "painting the tape" pre-market. The fact that the stock rallied all day long from the opening pre-market low at $6.61 all the way to trade $9.00 even just before the close speaks volumes. I wasn't in the May $8.00...

Nice little hammer bottom today... Shook the Tree down to 9.80 and came back to as high as 10.28 just before the close at 10.24

Right. You're the guy that said he sold an ENTIRE Oct. $10 Put for $270. Thanks for the laugh. :D

March/April has been the guidance for the data release. That has been known for awhile for anyone that has listened to the Company. As for "risks", if the data is solid the Company will be in a massive sprint to launch in Q1 of next year. They've already been preparing. One look at their Job...

The clinical study is BLINDED. After the data has been produced, a bio-statistician goes over the quality of the data. Once that has been completed, the study will become UNBLINDED and management will get their first view of the data. The data will then be announced to the public within...

Sorry man. I'm not hear to educate those here that are too f-ing lazy to educate themselves. The lack of "basics" expressed here about what this company is doing, the management team that is behind it,, let alone any concept of how BIG this market place is . . .is quite telling. The market...

Do yourself a favor and spend 20-30 minutes listening to the last quarterly conference call from Feb. 20th. You can find the audio portion link here: http://investor.exactsciences.com/events.cfm

PS. As to your "fast money" argument, you might want to go back to August of last year and take a look at how the stock "responded" to a 6.3 million share secondary offering at $9.75 Do you have any idea how many multi-billion dollar fund managers (who don't own a single share of stock) are...

I just got done writing 5 talking points about why all of the "above" is wrong, but decided to delete it because it's probably a waste of time educating people that claim that there's a lot of optimism given the current $680 million valuation, let alone mentioning a guy (Cramer) that the...

There is no Phase 1, Phase 2, or Phase 3 clinical trials. The Company is NOT developing a drug. Duh.

So why do you feel the need to "comment" on a Company and technology that you know nothing about?

Yup. That right there is 1.4 million potential annual tests. http://www.ncbi.nlm.nih.gov/pubmed?cmd=PureSearch&term=%28ahlquist%20da%5BAuthor%5D%20AND%20mayo%5BAll%20Fields%5D%29

The market-cap is only $670 million. There are 5.8 million shorts out there that have been betting on management not being able to execute. Thus far, they have met their guidance every step of the way.... and have only been one month behind their "time-line" that was offered over 2 years...